Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase IIb trial of ATL 1102 in patients with multiple sclerosis

Trial Profile

Phase IIb trial of ATL 1102 in patients with multiple sclerosis

Status: Planning
Phase of Trial: Phase II

Latest Information Update: 11 Dec 2014

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs ATL 1102 (Primary)
  • Indications Multiple sclerosis
  • Focus Therapeutic Use
  • Sponsors Antisense Therapeutics
  • Most Recent Events

    • 24 Oct 2014 According to Antisense Therapeutics media release, US FDA has responded affirmatively to the Company plan to submit a U.S. Investigational New Drug (IND) application for initiation of this phase II trial.
    • 19 Aug 2014 Antisense Therapeutics has submitted a formal request for the US FDA's assessment of ANP's plans for a Phase IIb trial of ATL1102 in MS patients.
    • 19 Mar 2013 Planned initiation date changed to 1 Jan 2014, based on information in an Antisense Therapeutics media release.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top